Pohjanvirta, Tarja
(Finnish Food Authority, 2022)
Finnish Food Authority Research Reports ; 3/2022
Mycoplasma bovis is an important pathogen of cattle. It causes a wide variety of clinical diseases, including mastitis, respiratory disease, arthritis, and otitis media. M. bovis has evolved several mechanisms to avoid the host’s immune system, no effective commercial vaccines are available, and antibiotic resistance is increasingly seen in contemporary strains. The most common route of transmission between herds is the purchase of a latent carrier animal. M. bovis can spread silently within a herd, and once established in a dairy herd it is difficult to eradicate. Hence, it is of utmost importance to try to control and prevent the spread of M. bovis. Sensitive and cost-effective diagnostic methods to detect latent carrier animals, as well as methods that could be used in herd certification are needed. The possible transmission of M. bovis through assisted reproduction needs to be investigated more closely. This thesis examines the course of M. bovis infection in Finnish dairy farms, presents a new route of entry of M. bovis into naive dairy herds, and describes methods that could be utilized in the control of M. bovis infections.
In study I, the course of M. bovis infection was followed over two years on 19 recently infected dairy farms. The aim was to identify diagnostic methods that could be used to assess whether the herd had reached a low-risk infection status. In 17 herds, a few cases of clinical mastitis were detected, and these mostly occurred within two months after the index case. On two farms, M. bovis only caused respiratory disease in young stock, and no clinical mastitis was detected. The prevalence of M. bovis in nasal (NS) and deep nasopharyngeal (NP) swabs taken from young calves varied from zero to 75% per herd among the studied calves. An in-house MilA ELISA detected more positive serum samples than the commercial BioX ELISA. The proportion of MilA-positive young stock followed the patterns seen in NS and NP of calves, but no such association was seen in BioX ELISA results. In cows, despite the infection appearing to have resolved in some herds, the proportion of MilA antibody-positive cows remained high for at least one and half year after the detection of the index case. According to the results, M. bovis can be present in calves alone without causing mastitis in cows. Several methods need to be applied to verify the herd infection status. These include regular monitoring for M. bovis in clinical mastitis and calf pneumonia cases, combined with regular PCR testing of nasal swabs from calves and sera for the detection of antibodies against M. bovis using the MilA ELISA.
The transmission of M. bovis via semen has been speculated. When epidemiological data to assess the infection source were collected in study I, suspicion arose that contaminated commercial artificial insemination (AI) semen could have been the source in two closed dairy herds. National health care and farm registers were used to collect farm data and farmers were interviewed. Whole genome sequencing was used to compare the genomes of isolated strains. Epidemiological analysis did not reveal any other source than contaminated semen from one bull used for artificial insemination in the cows that were the first ones to develop clinical mastitis in both herds. Core genome multilocus sequence type analysis supported this. The bull had secreted M. bovis intermittently and for only a short time into semen during an approximately seven-week period. On both farms, the incubation period between insemination and clinical mastitis was 32 days. To our knowledge, this is the first study to describe the transmission of M. bovis via AI. Even though this appears to be rare, commercial AI semen needs to be taken into account as a possible transmission route.
Following the detection of M. bovis in Finland, a voluntary control program was established. One part of the program is NS taken from young calves and tested for M. bovis to indicate the infection status of the herd. In study III, the suitability of this method was assessed and compared with NP sampling. Furthermore, NS and NP sampling of pneumonic calves to detect M. bovis was compared with bronchoalveolar lavage sampling. Altogether, 1037 NS were taken from calves in 30 recently infected herds, and NP samples were also taken from 284 calves. The overall prevalence in NS was 29.6% and the highest prevalence of 43% was seen in 31- to 60-day-old calves. Thereafter, the shedding rate decreased. At the calf level, NP sampling detected M. bovis in 47% and NS in 33% of studied calves. At the herd level, NS sampling was more sensitive, as it classified 51 out 54 herd visits with a positive infection status as infected, whereas using NP sampling, the respective figure was 43 out of 54 visits (p = 0.061). The reason for the difference seen at the calf and herd levels is the sampling protocol. We took only five NP samples, but number of NS swabs varied from six to 28, depending on the herd size. We conclude that NS swabs taken from calves under six months of age and analyzed with real-time PCR represent a cost-efficient method to be used in a control program. If calves suffering from acute respiratory disease need to be examined, NP samples are a practical and sensitive method to detect M. bovis.
The effect of two concentrations of a gentamycin-tylosin-linco/spectinomycin (GTLS) antibiotic combination and a fluoroquinole antibiotic, ofloxacin, on the viability of M. bovis in commercial-scale AI semen production using modern semen extender with plant-derived protein was investigated. A reference strain and a wild-type strains isolated from semen in study II were used in spiking. Three different protocols to extract M. bovis DNA from semen were also compared. At a high spiking concentration of 106 CFU/mL, none of the studied antibiotics had a bactericidal effect. At a low spiking concentration of 103 CFU/mL, the growth of the wild-type strain was inhibited by all other antibiotic protocols except for the low GTLS concentration, which is stated in EU regulation and the OIE Terrestrial Code. Instead, the high GTLS protocol was the only one that inhibited the growth of the reference strain. At a low M. bovis contamination level, GTLS used at a high concentration, according to the Certified Semen Services protocol, is more efficient than GTLS used according to the OIE Terrestrial Code. The Instagene™ matrix was the most efficient method to extract M. bovis DNA from semen.